These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9868037)

  • 1. [The peripheral blood levels of TNF alpha and PLA2 activities in dialysis and non-dialysis patients with uremia].
    Duan S; Luo J; Liu F
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):78-80. PubMed ID: 9868037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of type II phospholipase A2 and cytokines in patients with sepsis.
    Endo S; Inada K; Nakae H; Takakuwa T; Yamada Y; Suzuki T; Taniguchi S; Yoshida M; Ogawa M; Teraoka H
    Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):413-21. PubMed ID: 8746487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma type II phospholipase A2 levels in patients with acute pancreatitis.
    Miura M; Endo S; Kaku LL; Inoue Y; Sato N; Wakabayshi G; Baba E; Katsuya H; Inada K; Sato S
    Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):159-64. PubMed ID: 11758647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha as a uremic toxin: correlation with neuropathy, left ventricular hypertrophy, anemia, and hypertriglyceridemia in peritoneal dialysis patients.
    Espinoza M; Aguilera A; Auxiliadora Bajo M; Codoceo R; Caravaca E; Cirugeda A; del Peso G; Hevia C; Selgas R
    Adv Perit Dial; 1999; 15():82-6. PubMed ID: 10682077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha.
    Herbelin A; Nguyen AT; Zingraff J; Ureña P; Descamps-Latscha B
    Kidney Int; 1990 Jan; 37(1):116-25. PubMed ID: 2299797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group I and group II phospholipases A2 in serum in uraemia.
    Peuravuori HJ; Funatomi H; Nevalainen TJ
    Eur J Clin Chem Clin Biochem; 1993 Aug; 31(8):491-4. PubMed ID: 8218580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodialysis activates phospholipase A2 enzyme.
    Vishwanath BS; Fux CA; Uehlinger DE; Frey BM; Franson RC; Frey FJ
    Nephrol Dial Transplant; 1996 Jan; 11(1):109-16. PubMed ID: 8649616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling.
    Catar R; Moll G; Kamhieh-Milz J; Luecht C; Chen L; Zhao H; Ernst L; Willy K; Girndt M; Fiedler R; Witowski J; Morawietz H; Ringdén O; Dragun D; Eckardt KU; Schindler R; Zickler D
    Front Immunol; 2021; 12():774052. PubMed ID: 34858433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-8 in chronic renal failure and dialysis patients.
    Nakanishi I; Moutabarrik A; Okada N; Kitamura E; Hayashi A; Syouji T; Namiki M; Ishibashi M; Zaid D; Tsubakihara Y
    Nephrol Dial Transplant; 1994; 9(10):1435-42. PubMed ID: 7816257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Levels of tumor necrosis factor and interleukin 1 in uremia and in hemodialysis].
    Peona C; Fortina A; Colombo P; Filiberti O; Cagna G; Costantini L; Porcu M
    Minerva Urol Nefrol; 1991; 43(3):175-9. PubMed ID: 1726274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of uremia on tumor necrosis factor-alpha release after an in vitro whole-blood endotoxin challenge.
    Oettinger CW; Bland LA; Oliver JC; Arduino MJ; McAllister SK; Favero MS
    J Am Soc Nephrol; 1994 May; 4(11):1890-5. PubMed ID: 7919140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma interleukin-18 levels in hemodialysis patients: increased by dialysis process and association with interleukin-6 and tumor necrotic factor-alpha.
    Chiang CK; Huang JW; Hsu SP; Ho TI; Pai MF; Peng YS; Liu SH; Hung KY; Tsai TJ
    Blood Purif; 2006; 24(2):174-9. PubMed ID: 16357479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acid-base equilibrium in uremia: effect of continuous ambulatory peritoneal dialysis and hemodialysis].
    Nin Ferrari J; Santoro A; Fabbri L; Cavilli F; Zucchelli P
    G Clin Med; 1981 Sep; 62(9):624-33. PubMed ID: 7319174
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin.
    Pruzanski W; Wilmore DW; Suffredini A; Martich GD; Hoffman AG; Browning JL; Stefanski E; Sternby B; Vadas P
    Inflammation; 1992 Oct; 16(5):561-70. PubMed ID: 1428127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of type II phospholipase A2 and nitrite/nitrate in patients with burns.
    Yamada Y; Endo S; Kamei Y; Minato T; Yokoyama M; Taniguchi S; Nakae H; Inada K; Ogawa M
    Burns; 1998 Sep; 24(6):513-7. PubMed ID: 9776089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P
    J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phospholipase A2-related snake venom (from Crotalus durissus terrificus) stimulates neuroendocrine and immune functions: determination of different sites of action.
    Chisari A; Spinedi E; Voirol MJ; Giovambattista A; Gaillard RC
    Endocrinology; 1998 Feb; 139(2):617-25. PubMed ID: 9449633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRP, IL‑2 and TNF‑α level in patients with uremia receiving hemodialysis.
    Li G; Ma H; Yin Y; Wang J
    Mol Med Rep; 2018 Feb; 17(2):3350-3355. PubMed ID: 29257244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.